Company intelligence / Profile preview

Kremers Urban Development

Princeton, New Jersey, United Stateshuschblackwell.com ↗

Ownership: Private
Employees: ~67
Development stage: Commercial

Overview

Specialty generic pharmaceutical manufacturer with expertise in complex formulations and drug delivery technologies. Portfolio includes extended-release tablets/capsules, patches, liquids, and injectables for various therapeutic areas. Known for high fill rates and service levels. Now part of Lannett Company.

Therapeutic areas: GastroenterologyPulmonologyPsychiatryCardiovascular
Modalities: Small molecules (focus on complex generics and drug delivery systems)
Industry: Biotech

Drug pipeline

1 asset

omeprazole

Commercial

Indications: Acid reflux

Partnerships

Previously partnered with UCB S.A.; strategic alliances sought for product/drug delivery technology development pre-acquisition

Beyond the preview

Go deeper on Kremers Urban Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kremers Urban Development.

Explore the full profile